MasTec (MTZ) Backlog Hits $20.33b, Is The Stock Fully Priced?
MasTec, Inc. MTZ | 0.00 |
MasTec (MTZ) is back in focus after recent results highlighted a US$20.33b backlog and strong EPS growth. This points to operational progress that has helped underpin the stock's sharp move over the past six months.
At a share price of US$358.86, MasTec has seen strong share price momentum over the longer term, with a 57.64% year to date share price return and a 97.45% 1 year total shareholder return. However, the 30 day share price return is down 8.09%, hinting that shorter term enthusiasm has cooled slightly after recent results and backlog headlines.
If MasTec's infrastructure backlog has caught your attention, it could be a good moment to broaden your search and uncover 35 power grid technology and infrastructure stocks
After a near 100% 1 year return and a backlog standing at US$20.33b, MasTec’s setup now looks very different to a year ago. Do the current valuation and risk balance still lean in buyers’ favour?
Most Popular Narrative: 2.9% Overvalued
The most followed narrative currently places MasTec's fair value at $348.72, slightly below the last close at $358.86, which frames a relatively tight valuation gap.
Multi-year investments in operational efficiency, technology, and customer framework agreements are driving sequential and year-over-year improvements in EBITDA and net margins across segments; continued execution on these initiatives is likely to further support margin expansion and long-term earnings power, which appears underappreciated by the current stock valuation.
Curious what kind of revenue runway and margin profile need to line up with that fair value, and how analysts square it with the current P/E and future earnings curve? The narrative lays out a precise growth and profitability path, plus the discount rate and earnings multiple that have to hold for this pricing to make sense.
Result: Fair Value of $348.72 (OVERVALUED)
However, MasTec’s heavier spending on people and equipment, along with its reliance on large, concentrated customers, could quickly test this upbeat story if project timing slips.
Another View: MasTec Through the Cash Flow Lens
The first narrative framed MasTec as slightly overvalued relative to a US$348.72 fair value, yet our DCF model points in the opposite direction. On that view, MasTec at US$358.86 trades around 28.9% below an estimated future cash flow value of US$504.78. This raises the question: which story do you trust more, earnings multiples or long term cash generation potential?
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out MasTec for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 38 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
If the mix of optimism and concern around MasTec leaves you undecided, take a closer look at the numbers, the narratives, and the track record investors are focused on, then weigh the 4 key rewards and 2 important warning signs
Looking for more investment ideas beyond MasTec?
If MasTec has sharpened your focus, now is the time to widen your watchlist and uncover other stocks that could strengthen your overall portfolio.
- Spot potential value opportunities early by reviewing 38 high quality undervalued stocks that pair appealing pricing with solid underlying fundamentals.
- Strengthen your income stream by zeroing in on 7 dividend fortresses that aim to combine higher yields with robust business profiles.
- Prioritize resilience by filtering for 79 resilient stocks with low risk scores that may help balance out more volatile positions in your portfolio.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
